We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
(+6.2%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$14.8M |
| 2 |
Henry Schein
HSIC
|
+$14.3M |
| 3 |
Honeywell
HON
|
+$14.2M |
| 4 |
Pediatrix Medical
MD
|
+$13.5M |
| 5 |
Charles River Laboratories
CRL
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.1M |
| 2 |
CVS Health
CVS
|
+$18M |
| 3 |
Accendra Health
ACH
|
+$14.8M |
| 4 |
Ubiquiti
UI
|
+$13.1M |
| 5 |
Eagle Bancorp
EGBN
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.91% |
| 2 | Healthcare | 16.24% |
| 3 | Technology | 15.4% |
| 4 | Industrials | 13.98% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
DELISTED
Masimo
MASI
| $28.2M | 0.41% |
332,442
+50,156
| +18% | +$4.35M |
2015 Q2
10 quarters
|
|
77
DELISTED
Big Lots, Inc.
BIG
| $27.9M | 0.41% |
496,962
-7,291
| -1% | -$395K |
2015 Q2
10 quarters
|
|
78
NETGEAR
NTGR
$606M
| $27.4M | 0.4% |
465,588
+774
| +0.2% | +$39.6K |
2015 Q4
8 quarters
|
|
79
Bruker
BRKR
$8.64B
| $27M | 0.4% |
785,978
-20,170
| -3% | -$661K |
2013 Q2
18 quarters
|
|
80
Ryman Hospitality Properties
RHP
$8.68B
| $26.9M | 0.39% |
390,264
-5,736
| -1% | -$383K |
2016 Q3
5 quarters
|
|
81
Air Products & Chemicals
APD
$66.1B
| $26.6M | 0.39% |
161,978
+278
| +0.2% | +$44.3K |
2014 Q1
15 quarters
|
|
82
General Mills
GIS
$17.7B
| $26.4M | 0.39% |
445,147
-5,618
| -1% | -$304K |
2013 Q2
18 quarters
|
|
83
Deere & Co
DE
$175B
| $26M | 0.38% |
166,390
-7,535
| -4% | -$1.05M |
2013 Q2
18 quarters
|
|
84
Texas Roadhouse
TXRH
$11.2B
| $24.5M | 0.36% |
465,438
-6,996
| -1% | -$354K |
2013 Q4
16 quarters
|
|
|
COL
85
DELISTED
Rockwell Collins
COL
| $24.3M | 0.36% |
179,005
-81,091
| -31% | -$10.9M |
2013 Q2
18 quarters
|
|
86
Cheesecake Factory
CAKE
$5.84B
| $23.9M | 0.35% |
495,263
+21,802
| +5% | +$991K |
2014 Q3
13 quarters
|
|
87
New Jersey Resources
NJR
$5.24B
| $23.7M | 0.35% |
590,653
-8,926
| -1% | -$383K |
2013 Q2
18 quarters
|
|
88
UMB Financial
UMBF
$10.1B
| $23.5M | 0.34% |
326,583
-10,517
| -3% | -$772K |
2013 Q2
18 quarters
|
|
89
DELISTED
Coherent Inc
COHR
| $23.4M | 0.34% |
82,859
-1,774
| -2% | -$494K |
2013 Q2
18 quarters
|
|
90
Danaher
DHR
$162B
| $23.4M | 0.34% |
284,044
+18,849
| +7% | +$1.53M |
2015 Q1
11 quarters
|
|
91
Cohen & Steers
CNS
$3.58B
| $23.3M | 0.34% |
493,033
-8,881
| -2% | -$391K |
2013 Q2
18 quarters
|
|
92
Williams-Sonoma
WSM
$29.7B
| $23.2M | 0.34% |
897,722
-19,434
| -2% | -$495K |
2013 Q4
16 quarters
|
|
93
HUB Group
HUBG
$1.68B
| $23.1M | 0.34% |
965,308
+242,202
| +33% | +$5.33M |
2013 Q2
18 quarters
|
|
94
Flowers Foods
FLO
$1.3B
| $23.1M | 0.34% |
1,195,325
+15,549
| +1% | +$299K |
2014 Q3
13 quarters
|
|
95
Dorman Products
DORM
$3.7B
| $23M | 0.34% |
376,601
-11,602
| -3% | -$787K |
2013 Q2
18 quarters
|
|
96
Morningstar
MORN
$7.97B
| $22.9M | 0.34% |
236,040
-1,839
| -0.8% | -$166K |
2016 Q4
4 quarters
|
|
|
BMS
97
DELISTED
Bemis
BMS
| $22.2M | 0.33% |
464,108
-16,195
| -3% | -$749K |
2013 Q2
18 quarters
|
|
|
98
Honeywell
HON
$66.8B
| $22.1M | 0.32% |
159,822
+105,780
| +196% | +$14.2M |
2013 Q2
18 quarters
|
|
99
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $22.1M | 0.32% |
378,075
-9,342
| -2% | -$552K |
2013 Q3
17 quarters
|
|
100
Silgan Holdings
SLGN
$4B
| $21.8M | 0.32% |
741,885
+36,463
| +5% | +$1.06M |
2014 Q2
14 quarters
|
|
Similar funds
Boston Trust Walden's Q4 2017 Portfolio in Review
As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
- Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
- Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
- Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
- Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
- Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
- Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.
Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.